Achieving abstinence by treating depression in the presence of substance-use disorders

Addictive Behaviors

Volumn 29, Issue 6, 2004, Pages 1137-1141

  Hesse, Morten ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Depression; Meta analysis; Pharmacotherapy; Substance dependence

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ABSTINENCE; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COUNSELING; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG USE; HUMAN; META ANALYSIS; PSYCHOSOCIAL CARE; SUBSTANCE ABUSE;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 3242686346     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2004.03.006     Document Type: Article

References (23)

1. Altamura A.C., Mauri M.C., Giradi T., Panetta B. Alcoholism and depression: A placebo controlled study with viloxazine. International Journal of Clinical Pharmacology Research. 10:1990;293-298
2. Carroll K.M., Nich C., Rounsaville B.J. Variability in treatment-seeking cocaine abusers: Implications for clinical pharmacotherapy trials. NIDA Research Monograph. 175:1997
3. Cornelius J.R., Salloum I.M., Cornelius M.D., Perel J.M., Ehler J.G., Jarrett P.J., Levin R.L., Black A., Mann J.J. Preliminary report: Double blind, placebo-controlled study of fluoxetine in depressed alcoholics. Psychopharmacology Bulletin. 31(2):1995;297-303
4. Cornelius J.R., Salloum I.M., Ehler J.G., Jarrett P.J., Cornelius M.D., Perel J.M., Thase M.E., Black A. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Archives of General Psychiatry. 54(8):1997;700-705
5. Deeks J. Statistical methods programmed in MetaView. Version 4. Cochrane Library. 1999
6. Galloway G.P., Newmeyer J., Knapp T., Stalcup S.A., Smith D. Controlled trial of imipramine for the treatment of methamphetamine dependence. Journal of Substance Abuse Treatment. 13(6):1996;493-497
7. Johnson B.A., Jasinski D.R., Galloway G.P., Kranzler H., Weinreib R., Anton R.F., Mason B.J., Bohn M.J., Pettinati H.M., Rawson R., Clyde C. Ritanserin in the treatment of alcohol dependence - A multi-center clinical trial. Psychopharmacology. 128:1996;206-215
8. Lima M.S., Reisser A.A.P., Soares B.G.O., Farrell M. Antidepressants for cocaine dependence. Cochrane Library. 3:2002
9. Margolin A., Kosten T.R., Avants S.K., Wilkins J., Ling W., Beckson M., Arndt I.O., Cornish J., Ascher J.A., Li S.H. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug and Alcohol Dependence. 40(1):1995;123-131
10. Mason B.J., Kocsis J.H., Ritvo E.C., Cutler R.B. Double-blind, placebo controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA. 275(10):1996;761-767
11. McGrath P.J., Nunes E.V., Stewart J.W., Goldman D., Agosti V., Ocepek-Welikson K., Quitkin F.M. Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Archives of General Psychiatry. 53(3):1996;232-240
12. Nunes E.V. Methodologic recommendations for cocaine abuse clinical trials: A clinician-researcher's perspective. NIDA Research Monograph. 175:1997;93-95
13. Nunes E.V., McGrath P.J., Quitkin F.M., Ocepek-Welikson K., Stewart J.W., Koenig T., Wager S., Klein D.F. Imipramine treatment of cocaine abuse: Possible boundaries of efficacy. Drug and Alcohol Dependence. 39:1995;185-195
14. Nunes E.V., McGrath P.J., Quitkin F.M., Stewart J.P., Harrison W., Tricamo E., Ocepek-Welikson K. Imipramine treatment of alcoholism with comorbid depression. American Journal of Psychiatry. 150:1993;963-965
15. Nunes E.V., Quitkin F.M. Treatment of depression in drug-dependent patients: Effects on mood and drug use. NIDA Research Monograph. 172:1997;61-85
16. Nunes E.V., Quitkin F.M., Donovan S.J., Deliyannides D., Ocepek-Welikson K., Koenig T., Brady R., McGrath P.J., Woody G. Imipramine treatment of opiate-dependent patients with depressive disorders: A placebo-controlled trial. Archives of General Psychiatry. 55(2):1998;153-160
17. Petrakis I. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug and Alcohol Dependence. 50(3):1998;221-226
18. Roy A. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biological Psychiatry. 44:1998;633-637
19. Roy-Byrne P.P., Pages K.P., Russo J.E., Jaffe C., Blume A.W., Kingsley E., Cowley D.S., Ries R.K. Nefazodone treatment of major depression in alcohol-dependent patients: A double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology. 20(2):2000;129-136
20. Schmitz J.M., Averill P., Stotts A.L., Moeller F.G., Rhoades H.M., Grabowski J. Fluoxetine treatment of cocaine-dependent patients with major depression. Drug and Alcohol Dependence. 63(3):2001;207-214
21. Weiss R.D., Greenfield S.F., Najavits L.M. Integrating psychological and pharmacological treatment of dually diagnosed patients. NIDA Research Monograph. 150:1995
22. Woody G.E., O'Brien B.P., Rickels K. Depression and anxiety in heroin addicts: A placebo controlled study of doxepin in combination with methadone. American Journal of Psychiatry. 132:1975;447-450
23. Ziedonis D.M., Kosten T.R. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacology Bulletin. 27:1991;337-343